Key result
Severe neonatal enterovirus infection was associated with a 30.4% overall mortality rate, with the highest mortality of 38.6% observed in patients with myocarditis.
Why the study?
Neonates with enterovirus infection are at high risk for serious clinical manifestations and high mortality, prompting a systematic summary of clinical characteristics to guide identification and treatment.
Systematic Review (n=237)
Severe neonatal enterovirus infection carries a high overall mortality rate of 30.4%, which peaks at 38.6% in cases complicated by myocarditis, underscoring the need for early recognition and intensive supportive care.
Answers are grounded in this paper and cite their sources.
High mortality (30%) in severe neonatal EV, especially myocarditis; supports symptom-based recognition while leaving optimal therapies open for prospective trials.
Background: Enterovirus (EV) is a common cause of infection in neonates. Neonates are at high risk of enterovirus infection with serious clinical manifestations and high mortality. This review systematically summarized the clinical characteristics of neonates with severe enteroviral infection to provide evidence for the identification and treatment of severe neonatal EV infection. Methods : PubMed, Embase, and Web of Science were searched for original studies on neonates with severe EV infections from January 1, 2000, to November 27, 2020. Two reviewers independently screened the literature, extracted the data, and performed a descriptive analysis. Results : In total, 66 articles with 237 cases of severe neonatal enterovirus infection were included. All patients developed severe complications. Among them, 46.0% patients had hepatitis or coagulopathy, 37.1% had myocarditis, 11.0% had meningoencephalitis, and 5.9% had other complications such as hemophagocytic lymphohistiocytosis and pulmonary hemorrhage. The mortality rate of patients with severe infection was 30.4%. The highest mortality rate was 38.6%, which was observed in patients with myocarditis. In 70.5% patients, the age at the onset of symptoms was less than 7 days. Coxsackievirus B infection was seen in 52.3% patients. The most common symptoms included temperature abnormalities (127, 53.6%), rash (88, 37.1%), poor feeding (58, 24.5%), and respiratory symptoms (52, 21.9%). The main treatment included transfusion of blood components (42.2%), intravenous immunoglobulin (IVIG; 40.9%), mechanical ventilation (21.5%), and extracorporeal membrane oxygenation (ECMO; 18.1%). Additionally, antiviral medications pleconaril (14, 5.9%) and pocapavir (3, 1.3%) were administered. Conclusions : Mortality was high in patients with severe enterovirus infection, especially in those complicated with myocarditis. The most common symptoms included temperature abnormalities, rash, and poor feeding. The chief supportive treatment consisted of transfusion of blood components, mechanical ventilation, and ECMO. IVIG were widely used. Antiviral medications included pocapavir and pleconaril; however, more clinical evidence regarding their efficacy is needed.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) conducted a systematic review in Severe neonatal enterovirus infection (n=237). Severe enterovirus infection was evaluated on Mortality. Severe neonatal enterovirus infection was associated with a 30.4% overall mortality rate, with the highest mortality of 38.6% observed in patients with myocarditis.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: